BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6982311)

  • 1. Defective production of interferon-alpha associated with HLA-DW2 antigen in stable multiple sclerosis.
    Salonen R; Ilonen J; Reunanen M; Salmi A
    J Neurol Sci; 1982 Aug; 55(2):197-206. PubMed ID: 6982311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune functions in healthy blood donors with HLA-DW2 and -DW3 antigens.
    Ilonen J; Salonen R; Hyypiä T; Lankinen K; Karttunen R; Salmi A
    Immunobiology; 1986 Jul; 171(4-5):388-99. PubMed ID: 3488954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPD-, PWM-, and PHA-induced interferon in stable multiple sclerosis: association with HLA-Dw2 antigen and clinical variables.
    Salonen R; Ilonen J; Reunanen M; Nikoskelainen J; Salmi A
    Ann Neurol; 1982 Mar; 11(3):279-84. PubMed ID: 6178361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA and the response of lymphocytes to viral antigens in patients with multiple sclerosis.
    Walker JE; Cook JD; Harrison P; Stastny P
    Hum Immunol; 1982 Feb; 4(1):71-8. PubMed ID: 7061242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte blast transformation responses and viral antibodies in relation to HLA antigens in multiple sclerosis.
    Ilonen J; Reunanen M; Salmi A; Tiilikainen A
    J Neurol Sci; 1981 Jan; 49(1):117-33. PubMed ID: 6259296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
    Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
    Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal antibody synthesis to virus antigens in multiple sclerosis.
    Salmi A; Reunanen M; Ilonen J; Panelius M
    Clin Exp Immunol; 1983 May; 52(2):241-9. PubMed ID: 6407791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of HLA-Dw1 and -Dw2 positive adherent cells in antigen presentation to heterozygous T-cell lines: a low rubella antigen-specific response associated with HLA-Dw2.
    Ilonen J; Salmi A
    Hum Immunol; 1986 Oct; 17(2):94-101. PubMed ID: 2428786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-specific cytotoxic T cells in multiple sclerosis.
    McFarland HF; Goodman A; Jacobson S
    Ann N Y Acad Sci; 1988; 532():273-9. PubMed ID: 3263072
    [No Abstract]   [Full Text] [Related]  

  • 11. Viral infection in patients with multiple sclerosis and HLA-DR matched controls.
    Compston DA; Vakarelis BN; Paul E; McDonald WI; Batchelor JR; Mims CA
    Brain; 1986 Apr; 109 ( Pt 2)(2):325-44. PubMed ID: 3456817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-D typing with an association of Dw2 and absent immune responses towards herpes simplex (type i) antigen in multiple sclerosis.
    Paty DW; Cousin HK; Stiller CR; Boucher DW; Furesz J; Warren KG; Marchuk L; Dossetor JB
    Transplant Proc; 1977 Dec; 9(4):1845-8. PubMed ID: 203060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis.
    Cunningham AL; Nelson PA; Fathman CG; Merigan TC
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():249-58. PubMed ID: 2981967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-D typing in multiple sclerosis: Israelis tested with European homozygous typing cells.
    Brautbar C; Amar A; Cohen N; Oksenberg J; Cohen I; Kahana E; Bloch D; Alter M; Grosse-Wilde H
    Tissue Antigens; 1982 Mar; 19(3):189-97. PubMed ID: 6953617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
    Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles-specific T cell clones derived from a twin with multiple sclerosis: genetic restriction studies.
    Richert JR; McFarland HF; McFarlin DE; Johnson AH; Woody JN; Hartzman RJ
    J Immunol; 1985 Mar; 134(3):1561-6. PubMed ID: 2578511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype.
    Hillert J; Olerup O
    Neurology; 1993 Jan; 43(1):163-8. PubMed ID: 8093808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease.
    Söderström M; Hillert J; Link J; Navikas V; Fredrikson S; Link H
    Mult Scler; 1995 Nov; 1(3):173-80. PubMed ID: 9345450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
    Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
    J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of interferon production and natural killing by lymphocytes from multiple sclerosis patients.
    Neighbour PA
    Ann N Y Acad Sci; 1984; 436():181-91. PubMed ID: 6085226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.